| Literature DB >> 23717474 |
Cristina Zanini1, Elisabetta Ercole, Giorgia Mandili, Roberta Salaroli, Alice Poli, Cristiano Renna, Valentina Papa, Giovanna Cenacchi, Marco Forni.
Abstract
BACKGROUND: Medulloblastoma (MB) is an aggressive pediatric tumor of the Central Nervous System (CNS) usually treated according to a refined risk stratification. The study of cancer stem cells (CSC) in MB is a promising approach aimed at finding new treatment strategies. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2013 PMID: 23717474 PMCID: PMC3663798 DOI: 10.1371/journal.pone.0063748
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Morphology and medullosphere count derived from adherent MB tumor cells.
(A) Representative morphology of adherent cells and medullospheres in P1 and P4. (B) MBS count obtained with MB cell lines during different passages (P1–P10). Measurements were done in triplicate and data are presented as mean ± SD.
Figure 2Transmission electron microscopy.
MBS from DAOY (A), UW228 (B) and ONS-76 (C) show a uniform stem-like aspect characterized by a high N:C ratio; nucleus is irregularly shaped and cytoplasm appears sparsely organized with unspecific electron-dense organelles (B) and vacuoles (A). MB cell lines feature a low N:C ratio (D, E): nuclei exhibit an irregular profile and are peripherally located; the cytoplasm is populated by many organelles, such as RER, Golgi apparatus and mitochondria. On the contrary, ONS MB seem to maintain stemness appearance (F) as seen in the high N:C ratio with a kidney-shaped nucleus rimmed by a thin layer of cytoplasm.
Phenotypic analysis of stemness marker expression in medulloblastoma cell lines and in correspondent spheres.
|
|
|
|
| |||||||||
|
|
|
|
|
|
| |||||||
| CD133 |
|
|
|
|
|
|
|
|
|
|
|
|
| CD44 | 96.19 | ±5.30 | 97.41 | ±3.24 | 99.01 | ±1.36 | 95.21 | ±5.35 | 91.01 | ±1.23 | 98.81 | ±0.45 |
| Oct4 | 94.06 | ±4.65 | 90.78 | ±0.78 |
|
|
|
| 0.13 | ±0.13 | 0.74 | ±0.64 |
| Nanog | 93.88 | ±5.22 | 90.95 | ±0.72 | 94.27 | ±4.78 | 93.33 | ±3.45 | 0.59 | ±0.91 | 1.39 | ±1.12 |
| β-catenin |
|
|
|
|
|
|
|
|
|
|
|
|
| Nestin |
|
|
|
|
|
|
|
|
|
|
|
|
The table represents mean standard deviation of three independent experiments. Numbers in bold indicate a statistically significant difference of spheres with reference to the control adhesion conditions (*p<0,01).
Figure 3Analysis of MB and MDB expression by Flow cytometry.
FACS analyses shows expression of progenitor markers, CD133 (A) beta- catenin (B) and nestin (C), evaluated in both MB and in MBS for all cell lines by flow cytometry. Graphs represent pooled data from three independent determinations. Standard deviations and Student’s T-test were calculate to compare MB and MBS. Probability values less than 0.01 were considered significant.
Figure 4Migration assay.
Invasion capability of MB cells (ONS-76, DAOY and UW228) and their corresponding MBS (ONS-76 S, DAOY S and UW228 S) at 24h from experimental set up using a transwell (Matrigel) migration assay. The results are representative of two different experiments. Bar charts represent the mean of migrating cells evaluated in two independent experiments. *P<0,05 ***P<0,0001 (unpaired, two tailed t-test).
Figure 5Proteomic analysis.
Representative image from three independent experiments of Coomassie-stained 2-DE patterns of DAOY(A), UW228 (B) and ONS-76 (C) cell lines. Proteins were separated using 7-cm, pH-3-10 NL strips followed by SDSPAGE on 10%, 7×10-cm gels. Proteins showing differential expression were indicated with different colors: in blue –proteins identified in all cell lines and listed in Table 2; in black-proteins identified in adherent cells and spheres of each cell lines and in red-proteins only identified in spheres. Corresponding identifications are reported in Table 3, 4 and 5.
Proteins identified by MALDI-TOF in all (DAOY, UW228, ONS-76) Adherent and Sphere cell lines.
|
|
|
|
|
|
|
|
|
|
| CALR_HUMAN | P27797 | Calreticulin | 48283 | 4,29 | 8 | 30 | 81 | Adh/Sp |
| ENOA_HUMAN | Q6GMP2 | Alpha-enolase | 47481 | 7,01 | 9 | 40 | 48 | Adh/Sp |
| G3P_HUMAN | P04406 | Glyceraldehyde-3-phosphate dehydrogenase | 36201 | 8,57 | 7 | 28 | 74 | Adh/Sp |
| GRP78_HUMAN | P11021 | 78 kDa glucose-regulated protein | 72402 | 5,07 | 11 | 22 | 104 | Adh/Sp |
| HSP7C_HUMAN | P11142 | Heat shock cognate 71 kDa protein | 71082 | 5,37 | 10 | 16 | 76 | Adh/Sp |
| HSPB1_HUMAN | Q9UC36 | Heat shock protein beta-1 | 22826 | 5,98 | 8 | 34 | 132 | Adh/Sp |
| PARK7_HUMAN | Q99497 | Protein DJ-1 | 20050 | 6,33 | 16 | 72 | 179 | Adh/Sp |
| PRDX2_HUMAN | P32119 | Peroxiredoxin-2 | 22049 | 5,66 | 8 | 41 | 124 | Adh/Sp |
| TPIS_HUMAN | P60174 | Triosephosphate isomerase | 31057 | 5,65 | 12 | 41 | 158 | Adh/Sp |
| UCHL1_HUMAN | P09936 | Ubiquitin carboxyl-terminal hydrolase isozyme L1 | 25151 | 5,33 | 11 | 65 | 174 | Adh/Sp |
| VIME_HUMAN | Q8N850 | Vimentin | 53676 | 5,06 | 13 | 37 | 128 | Adh/Sp |
Abb, abbreviation.
AC, accession number.
MW, molecular weight.
pI, isoelectric point.
NVM, number of matched mass values on number of total mass values searched.
C%, the sequence coverage, which is calculated as the percentage of identified sequence to the complete sequence of the matched protein.
MS, mascot score.
CC, culture condition.
Proteins identified by MALDI-TOF only in DAOY Adherent and Sphere cell lines.
|
|
|
|
|
|
|
|
|
|
| ATP5H_HUMAN | O75947 | ATP synthase subunit d, mitochondrial | 18537 | 5,21 | 5 | 47 | 57 | Adh/Sp |
| HNRH1_HUMAN | P31943 | Heterogeneous nuclear ribonucleoprotein H | 49484 | 5,89 | 7 | 27 | 61 | Adh/Sp |
| IPYR_HUMAN | Q15181 | Inorganic pyrophosphatase | 33095 | 5,54 | 13 | 56 | 182 | Adh/Sp |
| LEG1_HUMAN | P09382 | Galectin-1 | 15048 | 5,34 | 9 | 73 | 130 | Adh/Sp |
| LGUL_HUMAN | Q04760 | Lactoylglutathione lyase | 20992 | 5,12 | 6 | 42 | 67 | Adh/Sp |
| NDKA_HUMAN | P15531 | Nucleoside diphosphate kinase A | 17309 | 5,83 | 10 | 78 | 145 | Adh/Sp |
| PDIA3_HUMAN | P30101 | Protein disulfide-isomerase A3 | 57146 | 5,98 | 12 | 32 | 134 | Adh/Sp |
| PDLI1_HUMAN | O00151 | PDZ and LIM domain protein 1 | 36505 | 6,56 | 9 | 33 | 88 | Adh/Sp |
| PPIA_HUMAN | Q9UC61 | Peptidyl-prolyl cis-trans isomerase A | 18229 | 7,68 | 9 | 74 | 126 | Adh/Sp |
| RANG_HUMAN | P43487 | Ran-specific GTPase-activating protein | 23467 | 5,19 | 9 | 43 | 105 | Adh/Sp |
| SODC_HUMAN | Q6NR85 | Superoxide dismutase [Cu-Zn] | 16154 | 5,7 | 5 | 38 | 72 | Adh/Sp |
| STIP1_HUMAN | P31948 | Stress-induced-phosphoprotein 1 | 63227 | 6,4 | 9 | 25 | 80 | Adh/Sp |
| TAGL2_HUMAN | P37802 | Transgelin-2 | 22548 | 8,41 | 7 | 43 | 84 | Adh/Sp |
| YBOX1_HUMAN | P67809 | Nuclease-sensitive element-binding protein 1 | 35903 | 9,87 | 8 | 28 | 79 | Adh/Sp |
| THIO_HUMAN | P10599 | Thioredoxin | 12015 | 4,82 | 4 | 54 | 60 | Adh/Sp |
| NPM_HUMAN | Q8WTW5 | Nucleophosmin | 32726 | 4,64 | 7 | 26 | 52 | Adh/Sp |
| CALL4_HUMAN | Q96GE6 | Calmodulin-like protein 4 | 21983 | 7,02 | 5 | 23 | 63 | Sp |
| CNDG2_HUMAN | Q86XI2 | Condensin-2 complex subunit G2 | 130960 | 06∶43 | 7 | 20 | 48 | Sp |
| GEMI5_HUMAN | Q8TEQ6 | Gem-associated protein 5 | 170821 | 6,17 | 7 | 7 | 56 | Sp |
| ICAL_HUMAN | P20810 | Calpastatin | 76572 | 4,97 | 8 | 8 | 43 | Sp |
| H2B1C_HUMAN | P62807 | Histone H2B type 1-C/E/F/G/I | 13898 | 10,31 | 9 | 43 | 84 | Sp |
| LMNA_HUMAN | P02545 | Prelamin-A/C | 74380 | 6,57 | 8 | 15 | 63 | Sp |
| PGK1_HUMAN | P00558 | Phosphoglycerate kinase 1 | 44985 | 8,3 | 10 | 28 | 105 | Sp |
| POC1A_HUMAN | Q8NBT0 | POC1 centriolar protein homolog A | 45008 | 07∶31 | 10 | 22 | 46 | Sp |
| TERA_HUMAN | P55072 | Transitional endoplasmic reticulum ATPase | 89950 | 5,14 | 7 | 14 | 60 | Sp |
Abb, abbreviation.
AC, accession number.
MW, molecular weight.
pI, isoelectric point.
NVM, number of matched mass values on number of total mass values searched.
C%, the sequence coverage, which is calculated as the percentage of identified sequence to the complete sequence of the matched protein.
MS, mascot score.
CC, culture condition.
Proteins identified by MALDI-TOF only in UW228 Adherent and Sphere cell lines.
|
|
|
|
|
|
|
|
|
|
| ACTA_HUMAN | P62736 | Actin, aortic smooth muscle | 42381 | 5,23 | 8 | 22 | 88 | Adh/Sp |
| ACTB_HUMAN | Q96HG5 | Actin, cytoplasmic 1 | 42052 | 5,29 | 10 | 21 | 60 | Adh/Sp |
| ACTC_HUMAN | P68032 | Actin, alpha cardiac muscle 1 | 42334 | 5,23 | 8 | 22 | 88 | Adh/Sp |
| ACTG_HUMAN | P63261 | Actin, cytoplasmic 2 | 42108 | 5,31 | 6 | 21 | 58 | Adh/Sp |
| ACTH_HUMAN | P63267 | Actin, gamma-enteric smooth muscle | 42249 | 5,31 | 6 | 22 | 88 | Adh/Sp |
| CALD1_HUMAN | Q05682 | Caldesmon | 93251 | 5,63 | 9 | 14 | 78 | Adh/Sp |
| CD11A_HUMAN | Q9UP54 | Cell division protein kinase 11A | 91146 | 5,34 | 6 | 10 | 56 | Adh/Sp |
| CRYAB_HUMAN | P02511 | Alpha-crystallin B chain | 20146 | 6,76 | 7 | 59 | 150 | Adh/Sp |
| PDIA1_HUMAN | P07237 | Protein disulfide-isomerase | 57480 | 4,76 | 10 | 25 | 106 | Adh/Sp |
| PDIA3_HUMAN | P30101 | Protein disulfide-isomerase A3 | 57146 | 5,98 | 9 | 18 | 84 | Adh/Sp |
| PGK1_HUMAN | P00558 | Phosphoglycerate kinase 1 | 44985 | 8,3 | 10 | 37 | 108 | Adh/Sp |
| PRDX1_HUMAN | Q06830 | Peroxiredoxin-1 | 22324 | 8,27 | 8 | 61 | 121 | Adh/Sp |
| TNIP2_HUMAN | Q8NFZ5 | TNFAIP3-interacting protein 2 | 49240 | 6,03 | 7 | 15 | 66 | Adh/Sp |
| TPM3_HUMAN | P06753 | Tropomyosin alpha-3 chain | 32856 | 4,68 | 8 | 16 | 74 | Sp |
| ALBU_HUMAN | Q9P157 | Serum albumin | 71317 | 5,92 | 8 | 14 | 63 | Sp |
| CALU_HUMAN | O43852 | Calumenin precursor | 34961 | 04∶46 | 15 | 11 | 49 | Sp |
| CATD_HUMAN | P07339 | Cathepsin D | 45037 | 6,1 | 11 | 26 | 118 | Sp |
| COF1_HUMAN | P23528 | Cofilin-1 | 18371 | 08∶26 | 12 | 22 | 55 | Sp |
| LEG1_HUMAN | P09382 | Galectin-1 | 15048 | 5,34 | 5 | 34 | 61 | Sp |
| MYL6_HUMAN | P60660 | Myosin light polypeptide 6 | 17090 | 4,56 | 10 | 50 | 112 | Sp |
| ROA2_HUMAN | P22626 | Heterogeneous nuclear ribonucleoproteins A2/B1 | 37464 | 8,97 | 9 | 27 | 91 | Sp |
| STMN1_HUMAN | P16949 | Stathmin | 17292 | 5,76 | 7 | 40 | 74 | Sp |
| NPM_HUMAN | Q8WTW5 | Nucleophosmin | 32726 | 4,64 | 15 | 30 | 60 | Sp |
Abb, abbreviation.
AC, accession number.
MW, molecular weight.
pI, isoelectric point.
NVM, number of matched mass values on number of total mass values searched.
C%, the sequence coverage, which is calculated as the percentage of identified sequence to the complete sequence of the matched protein.
MS, mascot score.
CC, culture condition.
Proteins identified by MALDI-TOF only in ONS-76 Adherent and Sphere cell lines.
|
|
|
|
|
|
|
|
|
|
| ARFRP_HUMAN | Q13795 | ADP-ribosylation factor-related protein 1 | 22614 | 07∶50 | 9 | 12 | 50 | Adh/Sp |
| CH60_HUMAN | P10809 | 60 kDa heat shock protein, mitochondrial | 61187 | 5,7 | 10 | 18 | 80 | Adh/Sp |
| CHSTE_HUMAN | Q8NCH0 | Carbohydrate sulfotransferase 14 | 43369 | 9,55 | 5 | 25 | 62 | Adh/Sp |
| FUBP1_HUMAN | Q96AE4 | Far upstream element-binding protein 1 | 67690 | 7,18 | 7 | 16 | 63 | Adh/Sp |
| GSHB_HUMAN | P48637 | Glutathione synthetase | 52523 | 5,67 | 15 | 39 | 178 | Adh/Sp |
| H2B1B_HUMAN | P33778 | Histone H2B type 1-B | 13942 | 10,31 | 5 | 46 | 80 | Adh/Sp |
| H2B1C_HUMAN | P62807 | Histone H2B type 1-C/E/F/G/I | 13898 | 10,31 | 9 | 43 | 84 | Adh/Sp |
| H2B1D_HUMAN | P58876 | Histone H2B type 1-D | 13928 | 10,31 | 9 | 43 | 84 | Adh/Sp |
| H2B1H_HUMAN | Q93079 | Histone H2B type 1-H | 13884 | 10,31 | 9 | 43 | 84 | Adh/Sp |
| H2B1J_HUMAN | P06899 | Histone H2B type 1-J | 13896 | 10,31 | 5 | 46 | 80 | Adh/Sp |
| H2B1K_HUMAN | O60814 | Histone H2B type 1-K | 13882 | 10,31 | 6 | 54 | 80 | Adh/Sp |
| H2B1L_HUMAN | Q99880 | Histone H2B type 1-L | 13944 | 10,31 | 9 | 43 | 84 | Adh/Sp |
| H2B1M_HUMAN | Q99879 | Histone H2B type 1-M | 13981 | 10,31 | 9 | 43 | 84 | Adh/Sp |
| H2B1N_HUMAN | Q99877 | Histone H2B type 1-N | 13914 | 10,31 | 9 | 43 | 84 | Adh/Sp |
| H2B1O_HUMAN | P23527 | Histone H2B type 1-O | 13898 | 10,31 | 5 | 46 | 80 | Adh/Sp |
| H2B2E_HUMAN | Q16778 | Histone H2B type 2-E | 13912 | 10,31 | 5 | 46 | 80 | Adh/Sp |
| HDGF_HUMAN | P51858 | Hepatoma-derived growth factor (HDGF) | 26788 | 4,7 | 6 | 22 | 56 | Adh/Sp |
| HMGB1_HUMAN | P09429 | High mobility group protein B1 | 25049 | 5,62 | 7 | 38 | 72 | Adh/Sp |
| HNRH1_HUMAN | P31943 | Heterogeneous nuclear ribonucleoprotein H | 49484 | 5,89 | 13 | 42 | 150 | Adh/Sp |
| HSP71_HUMAN | P08107 | Heat shock 70 kDa protein 1A/1B | 70294 | 5,48 | 8 | 18 | 82 | Adh/Sp |
| ICAL_HUMAN | P20810 | Calpastatin | 76925 | 4,98 | 9 | 19 | 79 | Adh/Sp |
| K1328_HUMAN | Q86T90 | Uncharacterized protein KIAA1328 | 66187 | 8,36 | 8 | 17 | 61 | Adh/Sp |
| KCY_HUMAN | P30085 | UMP-CMP kinase | 22436 | 5,44 | 6 | 34 | 70 | Adh/Sp |
| LMNA_HUMAN | P02545 | Prelamin-A/C | 74380 | 6,57 | 10 | 19 | 78 | Adh/Sp |
| NPM_HUMAN | P06748 | Nucleophosmin | 32,575 | 4,64 | 11 | 17 | 52 | Adh/Sp |
| OVCA2_HUMAN | Q8WZ82 | Ovarian cancer-associated gene 2 protein | 24,417 | 6,43 | 12 | 18 | 54 | Adh/Sp |
| PDLI1_HUMAN | O00151 | PDZ and LIM domain protein 1 | 36505 | 6,56 | 13 | 39 | 148 | Adh/Sp |
| PHB_HUMAN | P35232 | Prohibitin | 29843 | 5,57 | 12 | 61 | 174 | Adh/Sp |
| PON1_HUMAN | P27169 | Serum paraoxonase/arylesterase 1 | 39877 | 5,08 | 7 | 24 | 66 | Adh/Sp |
| PPIA_HUMAN | Q9UC61 | Peptidyl-prolyl cis-trans isomerase A | 18229 | 7,68 | 9 | 67 | 104 | Adh/Sp |
| SFPQ_HUMAN | P23246 | Splicing factor, proline- and glutamine-rich | 76216 | 9,45 | 10 | 22 | 85 | Adh/Sp |
| SODC_HUMAN | Q6NR85 | Superoxide dismutase [Cu-Zn] | 16154 | 5,7 | 5 | 38 | 67 | Adh/Sp |
Abb, abbreviation.
AC, accession number.
MW, molecular weight.
pI, isoelectric point.
NVM, number of matched mass values on number of total mass values searched.
C%, the sequence coverage, which is calculated as the percentage of identified sequence to the complete sequence of the matched protein.
MS, mascot score.
CC, culture condition.
Figure 6Immunostaining of TMA.
Staining for Oct-4, Sox-2, beta Catenin and Nucleophosim on DAOY, ONS76 and UW228 cell lines grown as spheres are shown at 40x magnification. UW228 (second column) show smaller spheres and less intense staining for Oct-4 and Sox-2.
Figure 7Stem cell Network.
The networks identified connect all proteins (nodes) already studied in Stem Cell in the literature. The node size is proportional to the number of papers where the proteins have been studied, while the edge width is proportional to the document number where two proteins have been described together. In the network representation, the group of nodes, white colored, identify the proteins commonly detected in Adh/Sp of the cells analyzed: DAOY (A), UW228 (B) and ONS-76 (C). The proteins overexpressed only in the Sp of each cell types are yellow colored. The specific cell type proteins identified in both Adh/Sp are green colored for DAOY, blue for UW228 and pink for ONS-76.
Biological Process Analysis MB cells.
|
| ||||
|
|
|
|
|
|
| 1,86E-05 | 7 | 25 | response to biotic stimulus | HIST1H2BC|VCP|HSPB1|PRDX2|HSPA5|HSPA8|ENO1 |
| 4,59E-05 | 3 | 11 | ER-nucleus signaling pathway | VCP|LMNA|HSPA5 |
| 7,86E-05 | 6 | 21 | negative regulation of programmed cell death | NPM1|HSPB1|GLO1|PRDX2|HSPA5|SOD1 |
| 1,72E-04 | 4 | 14 | nucleocytoplasmic transport | PDIA3|NPM1|LMNA|CALR |
| 1,76E-04 | 4 | 14 | nuclear transport | PDIA3|NPM1|LMNA|CALR |
| 1,76E-04 | 4 | 14 | glucose metabolic process | TPI1|PGK1|GAPDH|ENO1 |
| 2,70E-04 | 3 | 11 | oxygen and reactive oxygen species metabolic process | PRDX2|SOD1|PARK7 |
| 3,11E-04 | 5 | 18 | generation of precursor metabolites and energy | TPI1|TXN|PGK1|GAPDH|ENO1 |
| 4,98E-04 | 8 | 29 | regulation of signaling pathway | LGALS1|NPM1|UCHL1|PRDX2|HSPA5|SOD1|CALR|PARK7 |
| 5,75E-04 | 7 | 25 | homeostatic process | PDIA3|TXN|NPM1|PRDX2|SOD1|CALR|PARK7 |
| 6,69E-04 | 5 | 18 | regulation of protein kinase activity | NPM1|UCHL1|PRDX2|HSPA5|SOD1 |
|
| ||||
|
|
|
|
|
|
| 2,73E-06 | 8 | 27 | response to biotic stimulus | ACTA2|CFL1|HSPB1|PRDX2|STMN1|HSPA5|HSPA8|ENO1 |
| 4,28E-06 | 4 | 13 | glucose catabolic process | TPI1|PGK1|GAPDH|ENO1 |
| 9,73E-06 | 4 | 13 | oxygen and reactive oxygen species metabolic process | CRYAB|PRDX2|PRDX1|PARK7 |
| 1,08E-05 | 7 | 23 | negative regulation of programmed cell death | CRYAB|ALB|CFL1|NPM1|HSPB1|PRDX2|HSPA5 |
| 3,07E-05 | 7 | 23 | cytoskeleton organization | ACTC1|CRYAB|CALD1|CFL1|NPM1|STMN1|CALR |
| 1,56E-04 | 5 | 17 | actin filament-based process | MYL6|ACTC1|CALD1|CFL1|CALR |
| 8,28E-04 | 8 | 27 | regulation of signaling pathway | LGALS1|NPM1|UCHL1|PRDX2|HSPA5|CALR|PRDX1|PARK7 |
| 9,00E-04 | 7 | 23 | homeostatic process | P4HB|PDIA3|NPM1|PRDX2|CALR|PRDX1|PARK7 |
| 7,02E-03 | 4 | 13 | regulation of protein kinase activity | NPM1|UCHL1|PRDX2|HSPA5 |
|
| ||||
|
|
|
|
|
|
| 8,12E-07 | 8 | 29 | response to biotic stimulus | HIST1H2BC|HSPB1|HSPA1A|PRDX2|HSPD1|HSPA5|HSPA8|ENO1 |
| 3,82E-06 | 7 | 25 | negative regulation of programmed cell death | NPM1|HSPB1|HSPA1A|PRDX2|HSPD1|HSPA5|SOD1 |
| 1,76E-05 | 6 | 21 | cellular macromolecular complex assembly | HIST1H2BC|HIST1H2BD|HIST1H2BN|NPM1|HSPD1|CALR |
| 2,15E-05 | 4 | 14 | protein-DNA complex assembly | HIST1H2BC|HIST1H2BD|HIST1H2BN|NPM1 |
| 3,62E-05 | 4 | 14 | DNA recombination | HMGB1|PPIA|SFPQ|HSPD1 |
| 2,16E-04 | 3 | 11 | oxygen and reactive oxygen species metabolic process | PRDX2|SOD1|PARK7 |
| 4,67E-04 | 5 | 18 | regulation of protein kinase activity | NPM1|UCHL1|PRDX2|HSPA5|SOD1 |
| 2,24E-03 | 3 | 11 | nucleocytoplasmic transport | NPM1|LMNA|CALR |
| 2,28E-03 | 3 | 11 | nuclear transport | NPM1|LMNA|CALR |
| 2,28E-03 | 3 | 11 | glucose metabolic process | TPI1|GAPDH|ENO1 |
| 1,65E-03 | 7 | 25 | regulation of signaling pathway | NPM1|UCHL1|PRDX2|HSPA5|SOD1|CALR|PARK7 |
Figure 8The physical interactions network.
Protein-protein interaction are identify by pink edges. The black nodes, white edged represent the physical interactions of the common proteins differentially expressed in all DAOY, UW228 and ONS-76 adherent and sphere cell lines, while Sp overexpressed proteins are yellow edged and specific cell type DAOY(A), UW228 (B) and ONS-76 (C) Sp/Ads are green, blue and pink edged respectively. Grey proteins represented new interactions identified in Genemania proteomic databases. The edge width correspond to the weight of interaction.